We live a world which is undergoing significant change. Never in the history of life on the planet has there been more demand for the transformation of the Earth’s scarce raw materials into consumer goods for people around the globe. The world is being reorganized to facilitate the globalization of both demand and production, so the desires of people next door and in the farthest reaches of the planet can be communicated in real time to the millions of production and distribution chains around the world standing ready to fulfill them. At the same time, those very production processes are being challenged with the problem of how to satisfy these inexhaustible wants utilizing a finite set of scarce global resources.
Cesar Carnicer
ARTES Biotechnology has announced a collaboration with global pharmaceutical company, Boehringer Ingelheim Animal Health. ARTES Biotechnology specialises in recombinant protein production, process and vaccine development from microbial expression systems. ARTES’ expression system Hansenula polymorpha is the preferred technology for affordable mass vaccination and recommended by the World Health Organization (WHO) for these purposes. In combination with ARTES’ METAVAX® platform, this offers a new, unique and economical approach to low-cost mass production of safe and effective vaccines required in the veterinary field.
The protective agents released during the entire lactation remain active in the piglets’ intestines.
Dr Tomasz Trela
Get the latest news on Swine Health Subscribe to our newsletter